Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Repurposing Mirtazapine in Rett Syndrome: a Multicentric Open Label Phase II Study

NCT07430046 is registered in ClinicalTrials.gov with University of Trieste as lead sponsor.

NCT NCT07430046
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07430046 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Repurposing Mirtazapine in Rett Syndrome: a Multicentric Open Label Phase II Study
Lead sponsor
University of Trieste
Phase
Phase 2
Overall status
Recruiting
Start date
July 9, 2025
Completion date
December 31, 2026
Enrollment
54 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

rett syndrome with proven mecp2 mutation